End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,405 IDR | 0.00% | +0.36% | -12.73% |
01/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
20/02 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
Business Summary
Number of employees: 13,108
Sales per Business
IDR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Distribution and Logistic
36.6
%
| 10,801,381 | 37.3 % | 11,141,107 | 36.6 % | +3.15% |
Nutritionals
26.2
%
| 7,830,659 | 27.1 % | 7,985,307 | 26.2 % | +1.97% |
Prescription Pharmaceutical
25.0
%
| 6,148,609 | 21.3 % | 7,624,594 | 25.0 % | +24.01% |
Consumer Health
12.1
%
| 4,152,854 | 14.4 % | 3,698,125 | 12.1 % | -10.95% |
Sales per region
IDR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Indonesia
93.8
%
| 27,242,789 | 94.2 % | 28,559,990 | 93.8 % | +4.84% |
International
6.2
%
| 1,690,713 | 5.8 % | 1,889,144 | 6.2 % | +11.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vidjongtius
CEO | Chief Executive Officer | 59 | 01/97/01 |
Chairman | 61 | 01/97/01 | |
Danny Natalies
CTO | Chief Tech/Sci/R&D Officer | - | - |
Santoso Oen
BRD | Director/Board Member | 59 | 01/00/01 |
Public Communications Contact | 59 | 11/97/11 | |
General Counsel | 41 | 01/06/01 | |
Jessyca Sentosa
HRO | Human Resources Officer | - | - |
Mulialie
PRN | Corporate Officer/Principal | 54 | 27/21/27 |
Yuniar Linda
PRN | Corporate Officer/Principal | - | - |
Nurul H. Yusuf
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Santoso Oen
BRD | Director/Board Member | 59 | 01/00/01 |
Chairman | 61 | 01/97/01 | |
Ronny Hadiana
BRD | Director/Board Member | 52 | 01/15/01 |
Rhenald Kasali
BRD | Director/Board Member | 63 | 19/22/19 |
Lilis Halim
BRD | Director/Board Member | 63 | 22/19/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,875,122,110 | 18,960,573,673 ( 40.45 %) | 619,480,700 ( 1.322 %) | 40.45 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,504,801,795 | 92.47% | 383,885,923 $ | |
PT KALBE FARMA TBK. 1.32% | 619,480,700 | 1.32% | 57,630,290 $ |
Company contact information
PT Kalbe Farma Tbk
Gedung KALBE Jalan Let. Jend. Suprapto Kavling 4
10510, Jakarta
+62 21 4287 3888
http://www.kalbe.co.idSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.73% | 4.01B | |
+25.87% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+19.10% | 332B | |
+3.29% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.25% | 145B |
- Stock Market
- Equities
- KLBF Stock
- Company PT Kalbe Farma Tbk.